feed,title,long_url,short_url
Benzinga,"Oncternal Therapeutics Announces Strategic Reprioritization, Stops Two Zilovertamab Studies",https://benzinga.com/general/biotech/23/04/31656579/oncternal-therapeutics-announces-strategic-reprioritization-stops-two-zilovertamab-studies,https://da.gd/xA7c3
